Publications by authors named "Brandon Busbee"

Claim this Profile
S
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study.
Arshad M Khanani, David S Boyer, Charles C Wykoff, Carl D Regillo, Brandon G Busbee

EClinicalMedicine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased H3K4me3 methylation and decreased miR-7113-5p expression lead to enhanced Wnt/β-catenin signaling in immune cells from PTSD patients leading to inflammatory phenotype.
Marpe Bam, Xiaoming Yang, Brandon P Busbee, Allison E Aiello, Monica Uddin

Mol Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of cataract surgery in the United States for the year 2018.
Gary C Brown, Melissa M Brown, Brandon G Busbee

J Cataract Refract Surg· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational prediction and in vitro validation of VEGFR1 as a novel protein target for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kumaraswamy Naidu Chitrala, Xiaoming Yang, Brandon Busbee, Narendra P Singh, Laura Bonati

Sci Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.
Frank G Holz, Srinivas R Sadda, Brandon Busbee, Emily Y Chew, Paul Mitchell

JAMA Ophthalmol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD44 deletion leading to attenuation of experimental autoimmune encephalomyelitis results from alterations in gut microbiome in mice.
Kumaraswamy Naidu Chitrala, Hongbing Guan, Narendra P Singh, Brandon Busbee, Alexa Gandy

Eur J Immunol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
8
8 Questions with Darius Moshfeghi.
Brandon G Busbee

Ophthalmic Surg Lasers Imaging Retina· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration.
Carl D Regillo, Brandon G Busbee, Allen C Ho, Beiying Ding, Zdenka Haskova

Am J Ophthalmol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: To PMID 24246824.
Gary C Brown, Melissa M Brown, Alicia Menezes, Brandon G Busbee, Heidi B Lieske

Ophthalmology· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.
Allen C Ho, Brandon G Busbee, Carl D Regillo, Mark R Wieland, Sherri A Van Everen

Ophthalmology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Our advances are fabulous. Then what is the problem?
Gary C Brown, Brandon G Busbee

Curr Opin Ophthalmol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease.
Udai P Singh, Narendra P Singh, Hongbing Guan, Brandon Busbee, Robert L Price

Int Rev Immunol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptin antagonist ameliorates chronic colitis in IL-10⁻/⁻ mice.
Udai P Singh, Narendra P Singh, Hongbing Guan, Brandon Busbee, Robert L Price

Immunobiology· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cataract surgery cost utility revisited in 2012: a new economic paradigm.
Gary C Brown, Melissa M Brown, Alicia Menezes, Brandon G Busbee, Heidi B Lieske

Ophthalmology· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.
Brandon G Busbee, Allen C Ho, David M Brown, Jeffrey S Heier, Ivan J Suñer

Ophthalmology· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative medicines as emerging therapies for inflammatory bowel diseases.
Udai P Singh, Narendra P Singh, Brandon Busbee, H Guan, Balwan Singh

Int Rev Immunol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of ocular anesthesia: past and present.
Juanita S Bryant, Brandon G Busbee, Elias Reichel

Curr Opin Ophthalmol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
Jeffrey S Heier, Carl C Awh, Brandon G Busbee, L David Waterbury, Paul Daniel

Retina· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lidocaine hydrochloride gel for ocular anesthesia: results of a prospective, randomized study.
Brandon G Busbee, Abu Alam, Elias Reichel

Ophthalmic Surg Lasers Imaging· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endophthalmitis: a reappraisal of incidence and treatment.
Brandon G Busbee

Curr Opin Ophthalmol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on treatment strategies for bleb-associated endophthalmitis.
Brandon G Busbee

Curr Opin Ophthalmol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing trends in the microbiologic aspects of postcataract endophthalmitis.
Franco M Recchia, Brandon G Busbee, Robert B Pearlman, Cynthia A Carvalho-Recchia, Allen C Ho

Arch Ophthalmol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value-based medicine: a new paradigm to evaluate treatments for vitreoretinal diseases and other medical interventions.
Brandon G Busbee, Gary C Brown, Melissa M Brown

Int Ophthalmol Clin· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleb-associated endophthalmitis: clinical characteristics and visual outcomes.
Brandon G Busbee, Franco M Recchia, Richard Kaiser, Parveen Nagra, Brett Rosenblatt

Ophthalmology· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in knowledge and treatment: an update on endophthalmitis.
Brandon G Busbee

Curr Opin Ophthalmol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis